CANC vs. VIRS ETF Comparison
Comparison of Tema Oncology ETF (CANC) to Pacer BioThreat Strategy ETF (VIRS)
CANC
Tema Oncology ETF
CANC Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$27.57
Average Daily Volume
580
Number of Holdings
*
7
* may have additional holdings in another (foreign) market
VIRS
Pacer BioThreat Strategy ETF
VIRS Description
An exchange traded fund (ETF) that seeks to track the LifeSci BioThreat Strategy Index to invest in U.S. listed companies whose products or services help to protect against, endure or recover from biological threats to human health. The index aims to: Research of current and future pandemics. Combat agents of biological warfare. Detect the presence of biological threats. Secure national borders and ports and strengthen homeland security. Aid in stockpiling of products needed in times of natural disasters and disease outbreaks. Improve food and water safety and purity. Enable technology to benefit work and stay at home mandates.Grade (RS Rating)
Last Trade
$34.88
Average Daily Volume
106
Number of Holdings
*
52
* may have additional holdings in another (foreign) market
Performance
Period | CANC | VIRS |
---|---|---|
30 Days | 0.88% | -1.72% |
60 Days | -2.51% | -1.60% |
90 Days | 4.27% | 3.85% |
12 Months | 20.48% |
CANC Underweight 48 Positions Relative to VIRS
Symbol | Grade | Weight | |
---|---|---|---|
NVDA | C | -7.61% | |
NFLX | D | -5.43% | |
WMT | C | -5.23% | |
AMZN | A | -5.15% | |
TMO | C | -5.1% | |
DHR | C | -4.94% | |
LOW | D | -4.64% | |
ABT | D | -4.47% | |
HD | D | -4.44% | |
SNY | C | -4.37% | |
JNJ | F | -4.16% | |
CVS | F | -3.04% | |
GSK | A | -2.95% | |
ECL | A | -2.2% | |
MMM | A | -1.77% | |
PLTR | D | -1.66% | |
KMB | A | -1.62% | |
MRNA | B | -1.42% | |
KR | C | -1.41% | |
A | C | -1.4% | |
HLN | C | -1.36% | |
XYL | A | -1.11% | |
CHD | B | -0.93% | |
MTD | D | -0.93% | |
VLTO | A | -0.81% | |
BNTX | D | -0.73% | |
HRL | B | -0.68% | |
BAH | B | -0.66% | |
ZM | F | -0.65% | |
WAT | D | -0.64% | |
CLX | F | -0.64% | |
TDY | D | -0.63% | |
LH | F | -0.59% | |
DGX | A | -0.54% | |
AKAM | F | -0.54% | |
WBA | F | -0.53% | |
CPB | B | -0.48% | |
QGEN | C | -0.32% | |
SOLV | C | -0.3% | |
OGN | B | -0.16% | |
SRCL | F | -0.15% | |
FTRE | C | -0.11% | |
NEOG | F | -0.09% | |
TDOC | F | -0.08% | |
SCL | D | -0.07% | |
ENR | C | -0.07% | |
VIR | C | -0.04% | |
EBS | C | -0.0% |
CANC: Top Represented Industries & Keywords
Industries:
Drug Manufacturers - Major
Biotechnology
Diagnostics & Research
Keywords:
Medicine
S&P 500
Antibiotics
Biopharmaceutical
Biotechnology
Infectious Diseases
Inflammation
Nasdaq 100
Ophthalmology
Animal Health
Cancer
Cardiovascular Disease
Clinical Research
Colorectal Cancer
Lab Testing
Life Sciences
Macular Degeneration
Medication
Molecular Diagnostics
Respiratory Diseases
VIRS: Top Represented Industries & Keywords
Industries:
Diagnostics & Research
Biotechnology
Drug Manufacturers - Major
Household & Personal Products
Diversified Industrials
Home Improvement Stores
Packaged Foods
Specialty Chemicals
Business Services
Discount Stores
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Electronic Components
Grocery Stores
Health Care Plans
Health Information Services
Health Information Services
Media - Diversified
Medical Devices
Pharmaceutical Retailers